Erhard Seifried

13.0k total citations
298 papers, 7.7k citations indexed

About

Erhard Seifried is a scholar working on Hematology, Biochemistry and Genetics. According to data from OpenAlex, Erhard Seifried has authored 298 papers receiving a total of 7.7k indexed citations (citations by other indexed papers that have themselves been cited), including 129 papers in Hematology, 56 papers in Biochemistry and 50 papers in Genetics. Recurrent topics in Erhard Seifried's work include Blood transfusion and management (56 papers), Blood groups and transfusion (39 papers) and Hematopoietic Stem Cell Transplantation (36 papers). Erhard Seifried is often cited by papers focused on Blood transfusion and management (56 papers), Blood groups and transfusion (39 papers) and Hematopoietic Stem Cell Transplantation (36 papers). Erhard Seifried collaborates with scholars based in Germany, United States and Netherlands. Erhard Seifried's co-authors include W. Kurt Roth, Torsten Tonn, Reinhard Henschler, Michael Schmidt, Halvard Bönig, Gesine Bug, Christian Seidl, Hubert Schrezenmeier, Oliver G. Ottmann and Brigitte Rüster and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Blood.

In The Last Decade

Erhard Seifried

290 papers receiving 7.5k citations

Peers

Countries citing papers authored by Erhard Seifried

Since Specialization

Citations

This map shows the geographic impact of Erhard Seifried's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erhard Seifried with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erhard Seifried more than expected).

Fields of papers citing papers by Erhard Seifried

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erhard Seifried. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erhard Seifried. The network helps show where Erhard Seifried may publish in the future.

Co-authorship network of co-authors of Erhard Seifried

This figure shows the co-authorship network connecting the top 25 collaborators of Erhard Seifried. A scholar is included among the top collaborators of Erhard Seifried based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erhard Seifried. Erhard Seifried is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Phase 1b PK/PD Study to Demonstrate Antigen Elimination with RLYB212, A Monoclonal Anti-HPA-1a Antibody for FNAIT Prevention 2024 ·Thrombosis and Haemostasis ·Christof Geisen, (unknown), (unknown), Carmen Walter, (unknown), Jens Søndergaard Jensen, Douglas Sheridan, Kiran C. Patki, Róisín Armstrong, Bjøŕn Skogen, Frank Behrens, Erhard Seifried, Jens Kjeldsen‐Kragh, Mette Kjær, Michaela Köhm	0
2	Immune Plasma for the Treatment of COVID-19: Lessons Learned so far 2023 ·Hämostaseologie ·Hubert Schrezenmeier, (unknown), (unknown), (unknown), Bernd Jahrsdörfer, Erhard Seifried, Sixten Körper	2
3	An HPA-1a–positive platelet–depleting agent for prevention of fetal and neonatal alloimmune thrombocytopenia: a randomized, single-blind, placebo–controlled, single-center, phase 1/2 proof-of-concept study 2023 ·Journal of Thrombosis and Haemostasis ·Christof Geisen, Mette Kjær, (unknown), Bjøŕn Skogen, Róisín Armstrong, Frank Behrens, Zubin Bhagwagar, (unknown), Anette Mörtberg, (unknown), (unknown), Carmen Walter, Erhard Seifried, Agneta Wikman, Jens Kjeldsen‐Kragh, (unknown)	3
4	OC 02.1 Dose-Dependent Elimination of HPA-1a Platelets by Subcutaneous RLYB212, a Monoclonal Antibody to Prevent Fetal and Neonatal Alloimmune Thrombocytopenia 2023 ·Research and Practice in Thrombosis and Haemostasis ·Christof Geisen, (unknown), (unknown), Carmen Walter, Stefan Braeuninger, Jens Søndergaard Jensen, (unknown), D Sheridan, (unknown), Mette Kjær, Frank Behrens, Erhard Seifried, Jens Kjeldsen‐Kragh, Michaela Köhm	1
5	Zum Stellenwert von Rekonvaleszentenplasma bei der Therapie von COVID-19 2023 ·DMW - Deutsche Medizinische Wochenschrift ·Sixten Körper, Erhard Seifried, Hubert Schrezenmeier	0
6	Novel multiple swab method enables high efficiency in SARS‐CoV ‐2 screenings without loss of sensitivity for screening of a complete population 2020 ·Transfusion ·Michael Schmidt, Sebastian Hoehl, Annemarie Berger, Heinz Zeichhardt, (unknown), Sandra Ciesek, Erhard Seifried	23
7	Patient Blood Management Implementation Strategies and Their Effect on Physicians' Risk Perception, Clinical Knowledge and Perioperative Practice - the Frankfurt Experience 2015 ·Transfusion Medicine and Hemotherapy ·Dania Fischer, Kai Zacharowski, Markus Müller, Christof Geisen, Erhard Seifried, (unknown), Patrick Meybohm	28
8	Identification and Characterization of Circulating Variants of CXCL12 from Human Plasma: Effects on Chemotaxis and Mobilization of Hematopoietic Stem and Progenitor Cells 2014 ·Stem Cells and Development ·Rudolf Richter, (unknown), (unknown), (unknown), Erhard Seifried, Ulf Forssmann, Dennis Verzijl, Martine J. Smit, Xavier Blanchet, Philipp von Hundelshausen, Christian Weber, Wolf‐Georg Forssmann, Reinhard Henschler	28
9	Prediction of the pathogenicity of antithrombin sequence variations by in silico methods 2014 ·Thrombosis Research ·Beate Luxembourg, (unknown), (unknown), Erhard Seifried	15
10	A validation protocol and evaluation algorithms to determine compatibility of cell therapy product matrices in microbiological testing 2014 ·Cell and Tissue Banking ·Dieter Klarmann, Walid Sireis, Michael Hogardt, Volkhard A. J. Kempf, Erhard Seifried, Halvard Bönig	10
11	Variability in chemokine-induced adhesion of human mesenchymal stromal cells 2011 ·Cytotherapy ·(unknown), M. Giesen, Erika Deak, Victoria Lang, Erhard Seifried, Reinhard Henschler	18
12	A new HLA‐B08 allele, HLA‐B0828, found in two voluntary stem cell donors 2008 ·Tissue Antigens ·V. Brixner, Rudolf Richter, Peter Bader, Erhard Seifried, Christian Seidl	1
13	Recombinant expression of coagulation factor VIII in hepatic and non-hepatic cell lines stably transduced with third generation lentiviral vectors comprising the minimal factor VIII promoter 2007 ·Cytotherapy ·(unknown), Stefan Heinz, (unknown), (unknown), Dimas Tadeu Covas, Erhard Seifried, Torsten Tonn	13
14	HLA‐DRB10826 and HLA‐DQB10627, two novel class II alleles identified in blood stem cell donors of Caucasian origin 2006 ·Tissue Antigens ·V. Brixner, (unknown), Michael Schmidt, Stella Hermann, Erhard Seifried, Helmut Martin, Christian Seidl	6
15	Induction and Detection of Human Mesenchymal Stem Cell Migration in the 48-Well Reusable Transwell Assay 2005 ·Stem Cells and Development ·Brigitte Rüster, (unknown), Oliver Seitz, Erhard Seifried, Reinhard Henschler	38
16	Generation and Characterization of Human Hematopoietic Cell Lines Expressing Factor VIII 2002 ·Journal of Hematotherapy & Stem Cell Research ·Torsten Tonn, Christian Herder, Sven Becker, Erhard Seifried, Manuel Grez	20
17	Loco-regional thrombolysis for deep vein thrombosis: fact or fiction? A study of hemostatic parameters 2000 ·Blood Coagulation & Fibrinolysis ·Martin Grünewald, Martin Grießhammer, (unknown), Susanne Kuhn, Erhard Seifried, H.-H. Osterhues	6
18	Endogenous serum levels of thrombopoietic cytokines in healthy whole‐blood and platelet donors: implications for plateletpheresis 1999 ·British Journal of Haematology ·Frank Tacke, Patrick Schöffski, C Trautwein, Michael U. Martin, W Stangel, Erhard Seifried, Michael P. Manns, Arnold Ganser, Dennis R. Petersen	10
19	Sequence analysis and population data of short tandem repeat polymorphisms at loci D8S639 and D11S488 1999 ·International Journal of Legal Medicine ·Christian Seidl, Sarina Müller, (unknown), Erhard Seifried	4
20	Different effects of two methods of low‐density lipoprotein apheresis on the coagulation and fibrinolytic systems³ 1993 ·Journal of Internal Medicine ·(unknown), (unknown), M. Pfohl, (unknown), T. Risler, M. Eggstein, Erhard Seifried	46

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact